GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs on adipose tissue as well as the brain areas responsible for these interactions remain largely unknown. We found that central injection of a clinically used GLP-1R agonist, liraglutide, in mice stimulates brown adipose tissue (BAT) thermogenesis and adipocyte browning independent of nutrient intake. The mechanism controlling these actions is located in the hypothalamic ventromedial nucleus (VMH), and the activation of AMPK in this area is sufficient to blunt both central liraglutide-induced thermogenesis and adipocyte browning. The decreased body weight caused by the central injection of liraglutide in other hypothalamic sites was sufficiently explained by the suppression of food intake. In a longitudinal study involving obese type 2 diabetic patients treated for 1 year with GLP-1R agonists, both exenatide and liraglutide increased energy expenditure. Although the results do not exclude the possibility that extrahypothalamic areas are also modulating the effects of GLP-1R agonists, the data indicate that long-acting GLP-1R agonists influence body weight by regulating either food intake or energy expenditure through various hypothalamic sites and that these mechanisms might be clinically relevant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beiroa (36) et al. injected GLP-1 analog, liraglutide (LIR), into mice. LIR was found to stimulate the thermogenesis of brown adipose tissue and the browning of adipose cells, independent of the intake of nutrients. It can increase the thermogenesis and utilization of triacylglycerol-derived fatty acids and glucose in brown adipocytes and reduce the lipid content through the central GLP-1R agonist”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [36]
In the citing paper
“Nevertheless, the results showed reduced or unaltered REE in both studies after treatment with GLP-1 Ras, as opposed to the first studies, where GLP-1 RAs led to a raised REE, mainly when adjusted for fat-free mass [101].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [101]
In the citing paper
“Furthermore, a central injection of liraglutide in mice stimulated thermogenesis of BAT and browning of white adipocytes independently of nutrient intake [176].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [176]
In the citing paper
“In particular, feeding activates the secretion of periprandial gut hormones, such as CCK, GLP‐1, or secretin 105, 106, 107.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [105]
Citations
Cites
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 4×
“In agreement with previous findings (7,17,18), we found that the central stimulation of GLP-1R reduces food intake and body weight.”
BackgroundResultInfluentialGlucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundBuse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503 · cited 9×
“In addition to the functional data on liraglutide from the mouse study, we analyzed data from a cohort of obese patients with T2D who had been treated for 1 year with the antidiabetic drugs metformin and metformin in combination with the GLP-1R agonists exenatide and liraglutide (Table 1).”
BackgroundInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057
Cited by
Items 101–200 of 598
Carling, D., & Viollet, B. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.005 · Cited by 89
A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain
Graham, D. L., Durai, H. H., Trammell, T. S., Noble, B. L., Mortlock, D. P., Galli, A., & Stanwood, G. D. (2020) · Journal of Comparative Neurology · doi:10.1002/cne.24905 · Cited by 88
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Yu, J. H., Park, S. Y., Lee, D. Y., Kim, N. H., & Seo, J. A. (2022) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.22.001 · Cited by 103
Molecular and neuroendocrine mechanisms of cancer cachexia
Mendes, M. C. S., Pimentel, G. D., Costa, F. O., & Carvalheira, J. B. C. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0170 · Cited by 97
Gupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 101
Novel Browning Agents, Mechanisms, and Therapeutic Potentials of Brown Adipose Tissue
Wankhade, U. D., Shen, M., Yadav, H., & Thakali, K. M. (2016) · BioMed Research International · doi:10.1155/2016/2365609 · Cited by 100
Ghanim, H., Batra, M., Green, K., Abuaysheh, S., Hejna, J., Makdissi, A., Borowski, R., Kuhadiya, N. D., Chaudhuri, A., & Dandona, P. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14090 · Cited by 86
“Similarly, centrally infused liraglutide in mice activates GLP-1 receptor in the ventromedial nucleus of the hypothalamus, triggering AMPK inhibition and leading to sympathetic-induced BAT thermogenesis and browning of white adipose tissue.(11) It is of interest that, in the present study, the adipose tissue expressio…”
BackgroundResultInfluentialVogel, H., Wolf, S., Rabasa, C., Rodriguez-Pacheco, F., Babaei, C. S., Stöber, F., Goldschmidt, J., DiMarchi, R. D., Finan, B., Tschöp, M. H., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.039 · Cited by 86
“One such possible target is the arcuate nucleus, suggested to be an important mediator of food intake effects of GLP-1R activation by some studies (Beiroa et al., 2014; Secher et al., 2014), or an important mediator of blood glucose changes induced by GLP-1 by other studies (Sandoval et al.”
BackgroundCalcium Signaling Pathways: Key Pathways in the Regulation of Obesity
Song, Z., Wang, Y., Zhang, F., Yao, F., & Sun, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112768 · Cited by 94
“[149] found that it could facilitate brown adipose tissue”
BackgroundCheng, D., Yang, S., Zhao, X., & Wang, G. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s348055 · Cited by 84
“GLP-1 RA functions by activating the GLP-1 receptor (GLP-1R), and GLP-1R is widely located throughout the brain.(6,7) The ability of GLP-1 and its agonists to cross the blood–brain barrier suggests its therapeutic potential for NDs.”
BackgroundGlucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84
“Glutamate is considered the primary excitatory neurotransmitter in the CNS by exerting depolarization in the postsynaptic neurons.”
BackgroundInfluentialHypothalamic AMPK as a Mediator of Hormonal Regulation of Energy Balance
Wang, B., & Cheng, K. K. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113552 · Cited by 92
“Similar to GLP-1, targeted injection of the GLP-1 receptor agonist liraglutide or exendin-4 into the VMH inhibits food intake in humans and rodents [138,139].”
BackgroundSwitching on the furnace: Regulation of heat production in brown adipose tissue
Li, L., Li, B., Li, M., & Speakman, J. R. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.005 · Cited by 90
Epicardial adipose tissue feeding and overfeeding the heart
Iacobellis, G., & Barbaro, G. (2019) · Nutrition · doi:10.1016/j.nut.2018.07.002 · Cited by 82
Characterization of the genetic architecture of infant and early childhood body mass index
Helgeland, Ø., Vaudel, M., Solé-Navais, P., Flatley, C. J., Juodakis, J., Bačelis, J., Koløen, I. L., Knudsen, G. P., Johansson, B. B., Magnus, P. M., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00549-1 · Cited by 91
The Role of AMPK Signaling in Brown Adipose Tissue Activation
van der Vaart, J. I., Boon, M. R., & Houtkooper, R. H. (2021) · Cells · doi:10.3390/cells10051122 · Cited by 97
“creased the temperature of BAT, gene expression of thermogenic markers in BAT, brown‐ ing markers in WAT, and protein levels of UCP1 in both WAT and BAT [95].”
BackgroundThe significance of beige and brown fat in humans
Kiefer, F. W. (2017) · Endocrine Connections · doi:10.1530/ec-17-0037 · Cited by 86
Zhang, Z., Yang, D., Xiang, J., Zhou, J., Cao, H., Che, Q., Bai, Y., Guo, J., & Su, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60354 · Cited by 90
The importance of estradiol for body weight regulation in women
Vigil, P., Meléndez, J., Petkovic, G., & Río, J. P. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.951186 · Cited by 96
Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules
Song, N.-J., Chang, S., Li, D. Y., Villanueva, C. J., & Park, K. W. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.70 · Cited by 84
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
Tamayo‐Trujillo, R., Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Guevara‐Ramírez, P., Paz‐Cruz, E., Zambrano-Villacres, R., Simancas‐Racines, D., & Zambrano, A. K. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1398059 · Cited by 99
Brown Adipose Tissue Heterogeneity, Energy Metabolism, and Beyond
Shinde, A. B., Song, A., & Wang, Q. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651763 · Cited by 90
Regulation of brown fat by AMP-activated protein kinase
van Dam, A. D., Kooijman, S., Schilperoort, M., Rensen, P. C. N., & Boon, M. R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.07.003 · Cited by 83
Hypothalamic dopamine signalling regulates brown fat thermogenesis
Folgueira, C., Beiroa, D., Porteiro, B., Duquenne, M., Puighermanal, E., Fondevila, M. F., Barja-Fernández, S., Gallego, R., Hernández-Bautista, R., Castelao, C., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0099-7 · Cited by 86
Self-citationDecara, J., Rivera, P., Arrabal, S., Vargas, A., Serrano, A., Pavón, F. J., Dieguez, C., Nogueiras, R., Rodríguez de Fonseca, F., & Suárez, J. (2018) · Acta Physiologica · doi:10.1111/apha.13008 · Cited by 76
“Therefore, it is possible that both liraglutide and CL316243 enhance similar molecular mechanisms (eg via AMPK/ MAPK activation) controlling appetite suppression and energy balance through direct neuronal stimulation of an essential hypothalamic circuit(s) including the arcuate nucleus and paraventricular and ventrome…”
BackgroundInfluentialSelf-citationSF1-Specific AMPKα1 Deletion Protects Against Diet-Induced Obesity
Seoane-Collazo, P., Roa, J., Rial-Pensado, E., Liñares-Pose, L., Beiroa, D., Ruíz-Pino, F., López-González, T., Morgan, D. A., Pardavila, J. Á., Sánchez-Tapia, M. J., et al. (2018) · Diabetes · doi:10.2337/db17-1538 · Cited by 75
“From a therapeutic perspective, this evidence is relevant since several agents with potential antiobesity and/or antidiabetic effects, such as nicotine (13,37), metformin (38), and liraglutide (15), some of which are even in clinical use, act through AMPK, either peripherally or centrally.”
BackgroundSelf-citationEJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?
López, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0927 · Cited by 82
Hypothalamic AMPK as a Regulator of Energy Homeostasis
Huynh, M. K. Q., Kinyua, A. W., Yang, D. J., & Kim, K. W. (2016) · Neural Plasticity · doi:10.1155/2016/2754078 · Cited by 86
“Moreover, the GLP-1R agonist, liraglutide, was shown to dephosphorylate and hence inactivate AMPK leading to increased energy expenditure [123].”
BackgroundRecent Updates on Obesity Treatments: Available Drugs and Future Directions
Dragano, N. R. V., Fernø, J., Diéguez, C., López, M., & Milbank, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.034 · Cited by 84
Self-citationEstradiol effects on hypothalamic AMPK and BAT thermogenesis: A gateway for obesity treatment?
López, M., & Tena-Sempere, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.014 · Cited by 70
Self-citationBifari, F., Manfrini, R., Dei Cas, M., Berra, C., Siano, M., Zuin, M., Paroni, R., & Folli, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.025 · Cited by 69
Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
Michałowska, J., Miller-Kasprzak, E., & Bogdański, P. (2021) · Nutrients · doi:10.3390/nu13020351 · Cited by 68
“Consistent with these results, other studies in mice Nutrients 2021, 13, 351 7 of 32 revealed that central injection of liraglutide stimulates BAT thermogenesis and adipocyte browning through hypothalamic AMP-activated protein kinase (AMPK) [80], and the direct administration of GLP-1 into the dorsomedial hypothalamus…”
BackgroundInfluentialImmune Modulation of Brown(ing) Adipose Tissue in Obesity
van den Berg, S. M., van Dam, A. D., Rensen, P. C. N., de Winther, M. P. J., & Lutgens, E. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1066 · Cited by 67
MKK6 controls T3-mediated browning of white adipose tissue
Matesanz, N., Bernardo, E., Acín‐Pérez, R., Manieri, E., Perez‐Sieira, S., Hernández‐Cosido, L., Montalvo-Romeral, V., Mora, A., Rodríguez, E., Leiva‐Vega, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00948-z · Cited by 70
Self-citationThe key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
Zhao, L., Zhu, C., Lu, M., Chen, C., Nie, X., Abudukerimu, B., Zhang, K., Ning, Z., Chen, Y., Cheng, J., et al. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0374 · Cited by 67
Hypothalamic Regulation of Brown Adipose Tissue Thermogenesis and Energy Homeostasis
Zhang, W., & Bi, S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00136 · Cited by 77
“Studies have also shown that stimulation of the glucagon-like peptide-1 (GLP-1) system with GLP-1 analogs in the VMH increases BAT thermogenesis and WAT browning, leading to decreased body weight in a feeding-independent manner (75).”
BackgroundInfluentialProlonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21
Pena-León, V., Folgueira, C., Barja-Fernández, S., Pérez-Lois, R., Lima, N. D. S., Martin, M. J., Heras, V., Martínez-Martínez, S., Valero, P., Iglesias, C., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00602-z · Cited by 82
Self-citationSaglietto, A., Falasconi, G., Penela, D., Francia, P., Sau, A., Ng, F. S., Dusi, V., Castagno, D., Gaïta, F., Berruezo, A., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14292 · Cited by 76
“32 Among the different GLP-1 RAs, semaglutide was shown to have the highest efficacy in reducing body weight.”
Neuronal Control of Brown Fat Activity
Kooijman, S., van den Heuvel, J. K., & Rensen, P. C. N. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.008 · Cited by 71
“, due to shift work or light pollution) and human obesity? Among other compounds implemented in the treatment of T2DM is the GLP1 analog liraglutide that, in preclinical studies, has been shown to activate BAT and to induce browning of WAT via increased SNS outflow [63].”
BackgroundInfluentialRuiz, J. R., Martinez-Tellez, B., Sanchez-Delgado, G., Osuna-Prieto, F. J., Rensen, P. C. N., & Boon, M. R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.002 · Cited by 63
Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats
Krieger, J.-P., Santos da Conceição, E. P., Sanchez-Watts, G., Arnold, M., Pettersen, K. G., Mohammed, M., Modica, S., Lossel, P., Morrison, S. F., Madden, C. J., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00068.2018 · Cited by 63
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules · doi:10.3390/biom12020176 · Cited by 62
Xie, C., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090790 · Cited by 67
Abdalla, M. A., Deshmukh, H., Atkin, S., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821989238 · Cited by 60
Aging Effects on Epicardial Adipose Tissue
Iacobellis, G. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.666260 · Cited by 66
“EAT GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation (Yang et al., 2013; Beiroa et al., 2014; Dozio et al., 2019).”
Backgroundp53 in AgRP neurons is required for protection against diet-induced obesity via JNK1
Quiñones, M., Al-Massadi, O., Folgueira, C., Bremser, S., Gallego, R., Torres-Leal, L., Haddad-Tóvolli, R., García-Caceres, C., Hernandez-Bautista, R., Lam, B. Y. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05711-6 · Cited by 59
Self-citationPark, J., Kim, H., Jung, Y., Ahn, K. S., Kwak, H. J., & Um, J. (2019) · Nutrients · doi:10.3390/nu11091988 · Cited by 66
“Moreover, AMPK plays a crucial role in the activation of non-shivering thermogenesis in brown fat as well [58,59].”
BackgroundOrexins/Hypocretins: Key Regulators of Energy Homeostasis
Milbank, E., & López, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00830 · Cited by 63
Młynarska, E., Bojdo, K., Bulicz, A., Frankenstein, H., Gąsior, M., Kustosik, N., Rysz, J., & Franczyk, B. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100787 · Cited by 106
“These effects were mediated through central GLP-1 receptor signaling pathways, involving key regulators such as AMPK and sirtuin-1, a NAD+-dependent deacetylase [116–118].”
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
Geloneze, B., de Lima-Júnior, J. C., & Velloso, L. A. (2017) · Drugs · doi:10.1007/s40265-017-0706-4 · Cited by 60
Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance
Quiñones, M., Al-Massadi, O., Gallego, R., Fernø, J., Diéguez, C., López, M., & Nogueiras, R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.014 · Cited by 60
“To this end, we used adenoviruses encoding constitutively active forms of AMPK (AMPKa-CA) together with GFP or control adenovirus expressing GFP alone [22,23,25], injected stereotaxically into the ARC of rats ICV treated with vehicle or glucagon.”
MethodSelf-citationHypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat
López, M., Diéguez, C., & Nogueiras, R. (2015) · Adipocyte · doi:10.4161/21623945.2014.983752 · Cited by 59
“Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate.”
BackgroundSelf-citationMartínez de Morentin, P. B., Lage, R., González-García, I., Ruíz-Pino, F., Martins, L., Fernández-Mallo, D., Gallego, R., Fernø, J., Señarís, R., Saha, A. K., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1611 · Cited by 60
Self-citationChondronikola, M., Harris, L. L. S., & Klein, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12527 · Cited by 61
Suppression of GHS-R in AgRP Neurons Mitigates Diet-Induced Obesity by Activating Thermogenesis
Wu, C.-S., Bongmba, O., Yue, J., Lee, J., Lin, L., Saito, K., Pradhan, G., Li, D.-P., Pan, H.-L., Xu, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040832 · Cited by 59
Zhou, J., Poudel, A., Chandramani-Shivalingappa, P., Xu, B., Welchko, R., & Li, L. (2019) · Endocrine · doi:10.1007/s12020-018-1826-7 · Cited by 59
Hypothalamic AMPK as a possible target for energy balance-related diseases
López, M. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.04.007 · Cited by 63
The new era of drug therapy for obesity: the evidence and the expectations
Jones, B. J., & Bloom, S. R. (2015) · Drugs · doi:10.1007/s40265-015-0410-1 · Cited by 58
“A possible role for GLP-1 in stimulating energy utilization via BAT [27] requires further”
InfluentialWeight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Reiss, A. B., Gulkarov, S., Lau, R., Klek, S. P., Srivastava, A., Renna, H. A., & De Leon, J. (2025) · Biomolecules · doi:10.3390/biom15030408 · Cited by 58
“The mechanisms behind this usually involved brown adipose tissue thermogenesis [98,99].”
Iacobellis, G., & Baroni, M. G. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01687-1 · Cited by 56
GLP-1 programs the neurovascular landscape
Chen, B., Yu, X., HORVATH-DIANO, C., Ortuño, M. J., Tschöp, M. H., Jastreboff, A. M., & Schneeberger, M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.003 · Cited by 62
Lomenick, J. P., Buchowski, M. S., & Shoemaker, A. H. (2016) · Obesity · doi:10.1002/oby.21493 · Cited by 58
“GLP1RA may also increase energy expenditure (9-11).”
Wu, T., Rayner, C. K., & Horowitz, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_9 · Cited by 68
Maekawa, R., Seino, Y., Ogata, H., Murase, M., Iida, A., Hosokawa, K., Joo, E., Harada, N., Tsunekawa, S., Hamada, Y., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.010 · Cited by 56
“As an extra-pancreatic action, GLP-1 participates in resistance to body weight gain by slowing gastric emptying, suppressing appetite and increasing energy expenditure [8, 10, 11].”
BackgroundInfluentialFolgueira, C., Beiroa, D., Callon, A., Al–Massadi, O., Barja-Fernández, S., Senra, A., Fernø, J., López, M., Diéguez, C., Casanueva, F. F., et al. (2015) · Diabetes · doi:10.2337/db15-0889 · Cited by 58
“Intracerebroventricular cannulae were implanted stereotaxically in mice, as described previously (16).”
MethodSelf-citationRelevance of lipid metabolism for brown fat visualization and quantification
Schilperoort, M., Hoeke, G., Kooijman, S., & Rensen, P. C. N. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000296 · Cited by 55
“For example, preclinical studies demonstrated that BAT activity can be enhanced through glucagon-like peptide-1 (GLP-1) receptor signalling [37], which is activated by the gut hormone GLP-1, and activation of this signalling cascade enhances both the uptake of glucose and triglyceride-derived FA by BAT [38 & ].”
BackgroundQi, G., Zhou, Y., Zhang, X., Yu, J., Li, X., Cao, X., Wu, C., & Guo, P. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.004 · Cited by 54
Lim, J., Park, H. S., Kim, J., Jang, Y. J., Kim, J.-H., Lee, Y., & Heo, Y. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0528-4 · Cited by 60
Janssen, L. G. M., Nahon, K. J., Bracké, K. F. M., van den Broek, D., Smit, R., Sardjoe Mishre, A. S. D., Koorneef, L. L., Martinez-Tellez, B., Burakiewicz, J., Kan, H. E., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154167 · Cited by 54
van Eyk, H. J., Paiman, E. H. M., Bizino, M. B., IJzermans, S. L., Kleiburg, F., Boers, T. G. W., Rappel, E. J., Burakiewicz, J., Kan, H. E., Smit, J. W. A., et al. (2020) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.005 · Cited by 54
Zhang, F., Chen, Z., Wu, D., Tian, L., Chen, Q., Ye, Y., Chen, W., Wu, X., Wu, P., Yuan, W., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103382 · Cited by 54
Browning Epicardial Adipose Tissue: Friend or Foe?
Doukbi, E., Soghomonian, A., Sengenès, C., Ahmed, S., Ancel, P., Dutour, A., & Gaborit, B. (2022) · Cells · doi:10.3390/cells11060991 · Cited by 64
“The AMPK inactivation that leads to browning can be induced by thyroid hormones [172,173] or glucagon like peptide 1 receptor (GLP-1R) agonists [137].”
BackgroundUpdate on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management
Gallo, G., Desideri, G., & Savoia, C. (2024) · Nutrients · doi:10.3390/nu16162781 · Cited by 74
“Furthermore, GLP1-RA modulates lipid metabolism in white and brown adipose tissues, promoting brown adipose tissue thermogenesis and white adipose tissue browning [106,107].”
BackgroundOpposite Regulation of Ghrelin and Glucagon-like Peptide-1 by Metabolite G-Protein-Coupled Receptors
Engelstoft, M. S., & Schwartz, T. W. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.07.001 · Cited by 61
Elsanhoury, A., Nelki, V., Kelle, S., Van Linthout, S., & Tschöpe, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.720690 · Cited by 51
Fiorentino, T. V., Casiraghi, F., Davalli, A. M., Finzi, G., La Rosa, S., Higgins, P. B., Abrahamian, G. A., Marando, A., Sessa, F., Perego, C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.93091 · Cited by 51
Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Dias, S., Paredes, S., & Ribeiro, L. V. P. T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/2637418 · Cited by 57
“Liraglutide, through stimulation of CNS GLP-1R on ventromedial hypothalamic nuclei and modulation of AMPK pathway, was shown to decrease body weight [188], independently of the 5-HT2CR and MC4R pathways [179].”
BackgroundMetabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs
Renner, S., Blutke, A., Dobenecker, B., Dhom, G., Müller, T. D., Finan, B., Clemmensen, C., Bernau, M., Novak, I., Rathkolb, B., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.015 · Cited by 56
Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 53
Guðmundsdóttir, V., Pedersen, H., Allebrandt, K. V., Brorsson, C., van Leeuwen, N., Banasik, K., Mahajan, A., Groves, C. J., van de Bunt, M., Dawed, A. Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189886 · Cited by 52
Hypothalamic Estrogen Signaling and Adipose Tissue Metabolism in Energy Homeostasis
Irizarry, V. C. T., Jiang, Y., He, Y., & Xu, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898139 · Cited by 60
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases
Gaggini, M., Saponaro, C., & Gastaldelli, A. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0006 · Cited by 60
Type 2 Diabetes in the Elderly: Challenges in a Unique Patient Population
Bradley, D. P., & Hsueh, W. A. (2016) · Journal of Geriatric Medicine and Gerontology · doi:10.23937/2469-5858/1510014 · Cited by 67
Brain Ceramide Metabolism in the Control of Energy Balance
Cruciani‐Guglielmacci, C., López, M., Campaña, M. B., & Stunff, H. L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00787 · Cited by 55
“…leptin (Tanida et al., 2013), BMP8B (bone morphogenetic protein 8B) (Whittle et al., 2012;Martins et al., 2016), estrogens (Martinez deMorentin et al., 2014, 2015), glucagon-like-peptide 1 agonist (Beiroa et al., 2014) and nicotine (Martinez de Morentin et al., 2012; Seoane-Collazo et al., 2014).”
Central nicotine induces browning through hypothalamic κ opioid receptor
Seoane‐Collazo, P., Liñares‐Pose, L., Rial‐Pensado, E., Romero, A., Moreno‐Navarrete, J. M., Martínez‐Sánchez, N., Garrido‐Gil, P., Iglesias‐Rey, R., Morgan, D. A., Tomasini, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12004-z · Cited by 52
Self-citationGlucagon, GLP-1 and Thermogenesis
González-García, I., Milbank, E., Diéguez, C., López, M., & Contreras, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143445 · Cited by 49
Self-citationChen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178239 · Cited by 48
“Direct intra-hypothalamic GLP-1R agonism also induces anorexia (15, 17, 51–53).”
Burmeister, M. A., Brown, J. D., Ayala, J. E., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2017 · Cited by 48
Zhang, Y., Qu, Z., Lu, T., Shao, X., Cai, M., Dilimulati, D., Gao, X., Mao, W., Hu, F., Su, L., et al. (2023) · Nutrients · doi:10.3390/nu15030556 · Cited by 45
“Glucagon-like peptide 1 (GLP-1) is a peptide hormone released by gut enteroendocrine cells that improves glucose homeostasis and reduces body weight [12,13].”
BackgroundThe role of brown and beige adipose tissue in glycaemic control
Klepac, K., Georgiadi, A., Tschöp, M. H., & Herzig, S. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.001 · Cited by 51
Lee, J.-Y., Lee, M., Lee, J. Y., Bae, J., Shin, E., Lee, Y., Lee, B., Kang, E. S., & Soo, B. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0187 · Cited by 49
“Liraglutide, a glucagon-like protein-1 (GLP-1) receptor agonist, also stimulated BAT thermogenesis and WAT browning in a mouse model [18,19].”
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Besing, G.-L. K., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101718 · Cited by 50
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction
Janssen-Telders, C., Eringa, E. C., de Groot, J. R., de Man, F. S., & Handoko, M. L. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf056 · Cited by 64
“120,121 However, a reduction in EAT is likely accompanied by simultaneous reductions in other fat depots.”
Chien, C.-T., Jou, M.-J., Cheng, T.-Y., Yang, C.-H., Yu, T.-Y., & Li, P.-C. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.126 · Cited by 46
Holt, M. K., & Rinaman, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15576 · Cited by 57
Pharmacological Support for the Treatment of Obesity—Present and Future
Kosmalski, M., Deska, K., Bąk, B., Różycka-Kosmalska, M., & Pietras, T. (2023) · Healthcare · doi:10.3390/healthcare11030433 · Cited by 67
“Under the control of 5′AMP activated kinase in the ventromedial hypothalamus, they can promote the conversion of visceral white adipose tissue to brown adipose tissue, increasing thermogenesis and thus energy consumption [86].”
Hedin, K. A., Zhang, H., Kruse, V., Rees, V. E., Bäckhed, F., Greiner, T. U., Vazquez-Uribe, R., & Sommer, M. O. A. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00455 · Cited by 44
Gutierrez, A. D., Gao, Z., Hamidi, V., Zhu, L., Saint Andre, K. B., Riggs, K., Ruscheinsky, M., Wang, H., Yu, Y., Miller, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100813 · Cited by 44
“In mouse models, prolonged GLP1 analog treatment has been reported to induce AT browning.(11,14) IL-6 family cytokines have also been reported to induce AT browning through STAT3 signaling in mouse models.”
BackgroundHormones, Metabolism and the Benefits of Exercise
(2017) · Research and Perspectives in Endocrine Interactions · doi:10.1007/978-3-319-72790-5 · Cited by 44
Metadata
- Authors
- Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., Dieguez, C., Lopez, M., Frühbeck, G., & Nogueiras, R.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Spanish National Cancer Research Centre (ES)
- Centro de Investigación Biomédica en Red (ES)
- University of Bergen (NO)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-09-15
- Volume
- 63
- Issue
- 10
- Pages
- 3346-3358
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2108365604
- Cited by
- 602
- References
- 52
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 60 · 2023: 51 · 2022: 57 · 2021: 59 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 43 · 2016: 49 · 2015: 41 · 2014: 8
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, liraglutide, exenatide, brown adipose tissue thermogenesis, adipocyte browning, ventromedial hypothalamus, AMPK, energy expenditure, food intake regulation, body weight, obesity, type 2 diabetes, central nervous system
- MeSH terms
- Liraglutide, Exenatide, AMP-Activated Protein Kinase Kinases, Adult, Aged, Aged, 80 and over, Animals, Adipose Tissue, Brown, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Eating, Energy Metabolism, Female, Humans, Hypoglycemic Agents, Hypothalamus, Male, Metformin, Middle Aged, Obesity, Peptides, Protein Kinases, Venoms, Thermogenesis, Mice, Rats, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.